Impact of initial therapy with upadacitinib or adalimumab on achievement of 48-week treatment goals in patients with rheumatoid arthritis: post hoc analysis of SELECT-COMPARE
SELECT-COMPARE 研究的事后分析:初始治疗采用 upadacitinib 或 adalimumab 对类风湿关节炎患者 48 周治疗目标达成情况的影响
期刊:Rheumatology
影响因子:4.4
doi:10.1093/rheumatology/keac477
Mysler, Eduardo; Tanaka, Yoshiya; Kavanaugh, Arthur; Aletaha, Daniel; Taylor, Peter C; Song, In-Ho; Shaw, Tim; Song, Yanna; DeMasi, Ryan; Ali, Mira; Fleischmann, Roy